BG104654A - Method for treatment of chronic obstructive pulmonary disease (copd) - Google Patents

Method for treatment of chronic obstructive pulmonary disease (copd)

Info

Publication number
BG104654A
BG104654A BG104654A BG10465400A BG104654A BG 104654 A BG104654 A BG 104654A BG 104654 A BG104654 A BG 104654A BG 10465400 A BG10465400 A BG 10465400A BG 104654 A BG104654 A BG 104654A
Authority
BG
Bulgaria
Prior art keywords
copd
treatment
pulmonary disease
chronic obstructive
obstructive pulmonary
Prior art date
Application number
BG104654A
Other languages
Bulgarian (bg)
English (en)
Inventor
Siegfried Christensen
Theodore Torphy
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of BG104654A publication Critical patent/BG104654A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
BG104654A 1998-01-07 2000-08-01 Method for treatment of chronic obstructive pulmonary disease (copd) BG104654A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7071898P 1998-01-07 1998-01-07
US10690898P 1998-10-28 1998-10-28
PCT/US1999/000214 WO1999034798A1 (en) 1998-01-07 1999-01-06 Method for treating copd

Publications (1)

Publication Number Publication Date
BG104654A true BG104654A (en) 2001-04-30

Family

ID=26751429

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104654A BG104654A (en) 1998-01-07 2000-08-01 Method for treatment of chronic obstructive pulmonary disease (copd)

Country Status (33)

Country Link
US (1) US6369108B1 (de)
EP (1) EP1051172B1 (de)
JP (1) JP2003522095A (de)
KR (1) KR100555824B1 (de)
CN (1) CN1291891A (de)
AP (1) AP2000001859A0 (de)
AR (1) AR014411A1 (de)
AT (1) ATE285234T1 (de)
AU (1) AU752497B2 (de)
BG (1) BG104654A (de)
BR (1) BR9906803A (de)
CA (1) CA2317720A1 (de)
DE (1) DE69922786T2 (de)
DZ (1) DZ2703A1 (de)
EA (1) EA006382B1 (de)
EG (1) EG23945A (de)
ES (1) ES2234234T3 (de)
HU (1) HUP0100888A3 (de)
ID (1) ID26164A (de)
IL (1) IL137104A0 (de)
MA (1) MA26592A1 (de)
MY (1) MY133014A (de)
NO (1) NO20003481L (de)
NZ (1) NZ505521A (de)
OA (1) OA11443A (de)
PE (1) PE20000231A1 (de)
PL (1) PL341667A1 (de)
PT (1) PT1051172E (de)
SI (1) SI1051172T1 (de)
SK (1) SK285149B6 (de)
TR (1) TR200001819T2 (de)
UY (1) UY25338A1 (de)
WO (1) WO1999034798A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ3019A1 (fr) 1999-03-01 2005-05-20 Smithkline Beecham Corp Utilisation d'un inhibiteur de pde4 dans la préparation d'un médicament contre la copd.
AR024076A1 (es) * 1999-05-25 2002-09-04 Smithkline Beecham Corp Sales de cis-[4-ciano-4-(3-ciclopentiloxi-4-metoxifenil) ciclohexan-1-carboxilato]
HUP0202936A3 (en) * 1999-08-10 2003-11-28 Smithkline Beecham Corp 1,4-substituted 4,4-diaryl cyclohexanes, pharmaceutical compositions containing them and their use
EP1237851A4 (de) * 1999-12-15 2004-06-23 Smithkline Beecham Salze der i cis/i-4-cyano-4-3-(cyclopentyloxy)-4-methoxyphenyl]cyclhexan-1-carbonsäure
CA2402384A1 (en) 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Ltd. Benzylated pde4 inhibitors
DE10245153A1 (de) * 2002-09-27 2004-04-15 Infineon Technologies Ag Integrierter Feldeffekttransistor mit zwei Steuerbereichen, Verwendung dieses Feldeffekttranistors und Herstellungsverfahren
ES2382876T3 (es) 2005-05-31 2012-06-14 Pfizer, Inc. Compuestos de ariloxi-N-biciclometil-acetamida sustituidos como antagonistas de VR1
CN101679191B (zh) 2007-06-05 2014-03-12 塞诺菲-安万特股份有限公司 二杂芳基环己烷衍生物、其制备方法、用途及含有它们的药用组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0633771A4 (en) * 1992-04-02 1995-02-22 Smithkline Beecham Corporation Compounds.
FI944549L (fi) 1992-04-02 1994-11-30 Smithkline Beecham Corp Allergisten ja tulehdussairauksien hoidossa käyttökelpoiset yhdisteet
GB9525262D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas

Also Published As

Publication number Publication date
EP1051172A4 (de) 2002-08-14
EA200000740A1 (ru) 2001-02-26
EP1051172B1 (de) 2004-12-22
MA26592A1 (fr) 2004-12-20
TR200001819T2 (tr) 2000-11-21
JP2003522095A (ja) 2003-07-22
SI1051172T1 (en) 2005-06-30
AU752497B2 (en) 2002-09-19
HUP0100888A2 (hu) 2001-08-28
IL137104A0 (en) 2001-06-14
ES2234234T3 (es) 2005-06-16
DZ2703A1 (fr) 2003-09-01
SK10232000A3 (sk) 2001-01-18
EA006382B1 (ru) 2005-12-29
AU2106099A (en) 1999-07-26
PE20000231A1 (es) 2000-03-24
EG23945A (en) 2008-01-22
PT1051172E (pt) 2005-03-31
WO1999034798A1 (en) 1999-07-15
KR20010033909A (ko) 2001-04-25
MY133014A (en) 2007-10-31
NO20003481D0 (no) 2000-07-06
BR9906803A (pt) 2002-05-28
DE69922786T2 (de) 2005-06-23
ATE285234T1 (de) 2005-01-15
SK285149B6 (sk) 2006-07-07
US6369108B1 (en) 2002-04-09
HK1033551A1 (en) 2001-09-07
ID26164A (id) 2000-11-30
CN1291891A (zh) 2001-04-18
AR014411A1 (es) 2001-02-28
KR100555824B1 (ko) 2006-03-03
EP1051172A2 (de) 2000-11-15
NO20003481L (no) 2000-08-25
HUP0100888A3 (en) 2003-07-28
UY25338A1 (es) 2001-08-27
CA2317720A1 (en) 1999-07-15
AP2000001859A0 (en) 2000-09-30
PL341667A1 (en) 2001-04-23
NZ505521A (en) 2004-02-27
DE69922786D1 (de) 2005-01-27
OA11443A (en) 2004-04-28

Similar Documents

Publication Publication Date Title
NZ330216A (en) Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and use in treatment of atherosclerosis
CA2210022A1 (en) Paroxetine hydrochloride solvates
NO971520L (no) Fremgangsmåte for hemming av tilstander forbundet med neuropeptid Y
WO2001081312A3 (en) Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
MX9803809A (es) Inhibidores de hidroxamato de bifenilo de metaloproteinasas de matriz.
CA2283399A1 (en) Pyridazinones as inhibitors of cyclooxygenase-2
WO2003024391A3 (en) Treatment and prevention of mucositis in cancer patients
ZA9711279B (en) Method for treating and preventing neurological disorders and promoting wound healing.
AU7579194A (en) Methods for inhibiting angiogenisis and angiogenic diseases
IL126137A0 (en) New benzofuranone derivatives and a method for producing them
NO20000093L (no) (+)-Norcisaprid nyttig for 5-HT3 og 5-HT4-medierte forstyrrelser
IL126235A0 (en) Compounds with growth hormone releasing properties
CA2264005A1 (en) Piperazino derivatives as neurokinin antagonists
CA2218887A1 (en) Piperazino derivatives as neurokinin antagonists
AP2000001859A0 (en) Method for treating multiple sclerosis
AP2002002496A0 (en) Method and compositions for treating pulmonary diseases.
WO2003053352A3 (en) Therapeutic compounds for treating dyslipidemic conditions
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
CA2301590A1 (en) 2-aminopyridines as inhibitors of cyclooxygenase-2
GR3036241T3 (en) METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17-g(b)-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5-g(a)-ANDROST-1-EN-3-ONES.
EP0378146A3 (de) Polyamin-Derivate als antineoplastische Mittel
MXPA03006057A (es) Proceso para preparar (+) trans-4-p-fluorofenil -3 hidroximetil.
IL154915A0 (en) Method for producing chiral compounds
MX9604692A (es) Derivados de quinoxalina para el tratamiento de tinnitus.
HU9203052D0 (en) Method for treatment of hypertension